A multicentre prospective, open label, 3 weeks phase IV study to evaluate the efficacy and safety [of zolpidem] in elderly patients with insomnia in China

Trial Profile

A multicentre prospective, open label, 3 weeks phase IV study to evaluate the efficacy and safety [of zolpidem] in elderly patients with insomnia in China

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Zolpidem (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Acronyms STEP
  • Sponsors Sanofi
  • Most Recent Events

    • 12 Jun 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 12 Mar 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
    • 20 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top